HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

Ցույց տալ այլ տարբերակներ (1)

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Orkin, C, Montoto, S, Shaw, K, Okosun, J, Gandhi, S, Fields, P, Wilson, A, Shanyinde, M, Cwynarski, K, Marcus, R, De Vos, J, Young, A, Tenant-Flowers, M, Johnson, M, Chilton, D, Gribben, J, Bower, M
Ձևաչափ:	Journal article
Հրապարակվել է:	2012

Նմանատիպ նյութեր

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era
‌: Montoto, S, և այլն
Հրապարակվել է: (2011)

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
‌: Montoto, S, և այլն
Հրապարակվել է: (2012)

Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
‌: Bhanu Vakkalanka, և այլն
Հրապարակվել է: (2011-01-01)

The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
‌: Adam F. Binder, և այլն
Հրապարակվել է: (2017-10-01)

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
‌: Diego Villa, և այլն
Հրապարակվել է: (2018-12-01)

Tissue is the issue-sarcoidosis following ABVD chemotherapy for Hodgkin's lymphoma: a case report
‌: Subbiah Vivek, և այլն
Հրապարակվել է: (2007-11-01)

S202: CHILDBEARING AMONG CLASSICAL HODGKIN LYMPHOMA SURVIVORS TREATED WITH BEACOPP AND ABVD IN SWEDEN, DENMARK, AND NORWAY
‌: J. P. Entrop, և այլն
Հրապարակվել է: (2022-06-01)

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study
‌: Paolo Strati, և այլն
Հրապարակվել է: (2019-02-01)

A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
‌: Ryo Yonezawa, և այլն
Հրապարակվել է: (2023-01-01)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
‌: Schwenkglenks Matthias, և այլն
Հրապարակվել է: (2010-08-01)

Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
‌: Camille Cotteret, և այլն
Հրապարակվել է: (2020-04-01)

Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
‌: Marriam Mponda, և այլն
Հրապարակվել է: (2024-03-01)

Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
‌: Rebecca J. DeBoer, և այլն
Հրապարակվել է: (2020-11-01)

Advanced Hodgkin's lymphoma: results in 216 patients treated with ABVD in Brazil Linfoma de Hodgkin em estádio avançado: resultados do tratamento em 216 pacientes tratados com ABVD no Brasil
‌: Luciana Britto, և այլն
Հրապարակվել է: (2010-01-01)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
‌: Min Hu, և այլն
Հրապարակվել է: (2023-08-01)

T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
‌: Joshua P. Entrop, և այլն
Հրապարակվել է: (2022-10-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
‌: Vojin Vukovic, և այլն
Հրապարակվել է: (2023-08-01)

Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
‌: NIKITA SINGH, և այլն
Հրապարակվել է: (2022-01-01)

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD
‌: Chakraborty R, և այլն
Հրապարակվել է: (2015-03-01)

P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma
‌: Heidi Mocikova, և այլն
Հրապարակվել է: (2022-10-01)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
‌: Arun Seshachalam, և այլն
Հրապարակվել է: (2019-12-01)

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?
‌: Jillian R. Gunther, և այլն
Հրապարակվել է: (2020-07-01)

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.
‌: Greaves, P, և այլն
Հրապարակվել է: (2013)

P033 (0007) SINGLE CENTER ANALYSIS OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA: FOCUS ON R-ABVD AND INTERIM PET
Հրապարակվել է: (2018-10-01)

Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
‌: Marc P. E. André, և այլն
Հրապարակվել է: (2020-09-01)

Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
‌: Alessandro Cellini, և այլն
Հրապարակվել է: (2024-09-01)

Brentuximab vedotin followed by ABVD +/− radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
‌: Massimo Federico, և այլն
Հրապարակվել է: (2016-04-01)

Survival rates of adult patients with Hodgkin lymphoma who underwent ABVD versus escalated BEACOPP in a resource‐limited country: An observational study
‌: Tawatchai Suwanban, և այլն
Հրապարակվել է: (2023-08-01)

P1081: PET-ADAPTED THERAPY AFTER THREE CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA: LONG TERM FOLLOW UP OF THE GATLA LH-05 TRIAL
‌: A. Pavlovsky, և այլն
Հրապարակվել է: (2022-06-01)

Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
‌: Rogério Pinto Giesta, և այլն
Հրապարակվել է: (2009-06-01)

FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin’s disease-a useful tool for monitoring pulmonary toxicity and disease activity
‌: T. Buchler, և այլն
Հրապարակվել է: (2007-11-01)

A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era
‌: Mercy M. Mbai, և այլն
Հրապարակվել է: (2024-07-01)

Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
‌: Rachel Broadbent, և այլն
Հրապարակվել է: (2023-11-01)

P030 (0143) ONCE-A-CYCLE VS. DAILY G-CSF IN EARLY-UNFAVORABLE STAGES OF HODGKIN LYMPHOMA TREATED WITH BEACOPP ESCALATED FOLLOWED BY ABVD
Հրապարակվել է: (2018-10-01)

P1082: SAFETY AND EFFICACY ANALYSIS IN OLDER PATIENTS TREATED WITHIN THE GATLA LH-05 PROTOCOL: PET-ADAPTED THERAPY AFTER 3 CYCLES OF ABVD FOR ALL STAGES OF HODGKIN LYMPHOMA
‌: N. L. Fiad, և այլն
Հրապարակվել է: (2022-06-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
‌: Ercole Brusamolino, և այլն
Հրապարակվել է: (2012-04-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
‌: Ercole Brusamolino, և այլն
Հրապարակվել է: (2014-08-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
‌: Ercole Brusamolino, և այլն
Հրապարակվել է: (2012-01-01)

THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY
‌: Ercole Brusamolino, և այլն
Հրապարակվել է: (2014-08-01)

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
‌: Michael Dickinson, և այլն
Հրապարակվել է: (2023-08-01)